Intended for healthcare professionals

Letters Adverse effects of statins

Information about diabetogenic effect of statins is inadequate in France

BMJ 2014; 349 doi: (Published 15 July 2014) Cite this as: BMJ 2014;349:g4385
  1. Frédérick Stambach, general practitioner1,
  2. Philippe Nicot, general practitioner, expert for the Haute Autorité de Santé, and vice president of the FORMINDEP Association2,
  3. Jean Doubovetzky, general practitioner and senior writer for Prescrire journal3
  1. 1Lieudit La Mareille, 87400 Moissannes, France
  2. 275 Avenue Léon Blum, 87350 Panazol, France
  3. 330 Rue Jules Amilhau, Résidence Chantilly, bâtiment B, appartement 65, 31100 Toulouse, France
  1. stambach.fred{at}

We analysed the official information available in France for healthcare professionals and patients about the diabetogenic effect of statins after reading the editorial by Godlee.1

In March 2012, the European Medicines Agency (EMA) acknowledged the diabetogenic effect of statins and demanded that summaries of product characteristics and package leaflets for all statins be modified.2

We …

View Full Text

Log in

Log in through your institution


* For online subscription